| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.417 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.417 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.417 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.417 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
0.417 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.417 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.417 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.417 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
0.417 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
0.417 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
0.417 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
0.417 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.417 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
0.417 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| IGF2R |
IGF2R, MPRI: Cation-independent mannose-6-phosphate receptor precursor |
GGA3 |
GGA3, KIAA0154: ADP-ribosylation factor-binding protein GGA3 |
0.417 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.417 |
Evidence |
|